Loading...
Based on the data provided, SBC Medical Group Holdings Inc is not a strong buy at this moment for a beginner investor with a long-term strategy. The lack of positive trading signals, no significant news catalysts, and mixed financial performance suggest holding off on investment until clearer opportunities emerge.
The MACD is negatively expanding, indicating bearish momentum. RSI is neutral at 28.257, and moving averages are converging, showing no clear trend. The stock is trading near its support level of 3.877, with resistance at 4.251.
Net income increased significantly by 352.70% YoY in Q3 2025, and EPS grew by 300.00% YoY, indicating improved profitability.
No recent news or significant trading trends from hedge funds or insiders.
In Q3 2025, revenue declined significantly (-18.33% YoY), but net income and EPS showed strong growth (352.70% and 300.00% YoY, respectively). Gross margin decreased to 70.61%, down -13.31% YoY.
No data available for analyst ratings or price target changes.